Abstract
In 1988, a new strain of avian leukosis virus (ALV) was isolated from meat‐type chickens in the UK. Studies on the prototype virus strain, HPRS‐103, placed it in a new envelope subgroup, designated J. The envelope gene of subgroup J ALV (ALV‐J) is closely related to endogenous retroviral sequences of the EAV family present in the normal chicken genome, suggesting that ALV‐J is a genetic recombinant. Sequence studies on the envelope gene of various field isolates of ALV‐J indicate the occurrence of frequent mutations leading to antigenic variation. Experimentally and in the field, HPRS‐103 and related viruses cause predominantly myeloid leukosis (myelocytomatosis: ML) and a variety of less common tumours, with experimentally a latent period between infection and the onset of ML mortality of 9 or more weeks and a median age at death of 20 weeks. The frequency of tumours varies considerably between lines of chickens. From some cases of ML, acutely‐transforming variant viruses can be isolated which are more rapidly tumourigenic. Cell tropism studies revealed that HPRS‐103 has a low tropism for bursal follicle cells, but high tropism for cultured blood monocytes. ALV‐J can be detected in the field using conventional ALV isolation and characterization methods. Recently, PCR assays specific for ALV‐J have been developed. Serum antibodies to ALV‐J can be detected using virus neutralization techniques and ELISA tests using crude antigen from ALV‐J infected fibroblasts or purified antigen produced in a baculovirus system. ALV‐J spreads vertically through the embryo and horizontally by contact, producing tolerant viraemic birds and immune birds, respectively. All birds of the former class are shedders and transmitters of ALV‐J to their progeny, as are a few birds in the immune class. Meat‐type birds infected soon after hatching are particularly prone to becoming tolerant also. Shedder hens can be identified by testing vaginal swabs and egg albumen for ALV group‐specific antigen by an ELISA, allowing ALV‐J eradication protocols to be designed. Commercial application of such an eradication programme over several years has resulted in a marked reduction in the prevalence of virus in infected breeding flocks.